Rani Therapeutics Holdings (RANI) Accumulated Depreciation & Amortization (2020 - 2024)
Rani Therapeutics Holdings (RANI) has 5 years of Accumulated Depreciation & Amortization data on record, last reported at $107000.0 in Q4 2024.
- For Q4 2024, Accumulated Depreciation & Amortization rose 101.8% year-over-year to $107000.0; the TTM value through Dec 2024 reached $107000.0, up 101.8%, while the annual FY2024 figure was $107000.0, 101.8% up from the prior year.
- Accumulated Depreciation & Amortization reached $107000.0 in Q4 2024 per RANI's latest filing, up from -$5.9 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $107000.0 in Q4 2024 and bottomed at -$5.9 million in Q4 2023.
- Average Accumulated Depreciation & Amortization over 5 years is -$2.1 million, with a median of -$1.6 million recorded in 2022.
- Peak YoY movement for Accumulated Depreciation & Amortization: crashed 279.58% in 2023, then surged 101.8% in 2024.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at -$1.6 million in 2020, then increased by 6.48% to -$1.5 million in 2021, then fell by 1.56% to -$1.6 million in 2022, then plummeted by 279.58% to -$5.9 million in 2023, then soared by 101.8% to $107000.0 in 2024.
- Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $107000.0 in Q4 2024, -$5.9 million in Q4 2023, and -$1.6 million in Q4 2022.